Sunshine Act Meeting, 8584-8585 [2022-03291]

Download as PDF lotter on DSK11XQN23PROD with NOTICES1 8584 Federal Register / Vol. 87, No. 31 / Tuesday, February 15, 2022 / Notices collection burden for small business concerns with fewer than 25 employees.’’ The Commission may not conduct or sponsor a collection of information unless it displays a currently valid Office of Management and Budget (OMB) control number. No person shall be subject to any penalty for failing to comply with a collection of information subject to the PRA that does not display a valid OMB control number. DATES: Written comments and recommendations for the proposed information collection should be submitted on or before March 17, 2022. ADDRESSES: Comments should be sent to www.reginfo.gov/public/do/PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. Your comment must be submitted into www.reginfo.gov per the above instructions for it to be considered. In addition to submitting in www.reginfo.gov also send a copy of your comment on the proposed information collection to Nicole Ongele, FCC, via email to PRA@fcc.gov and to Nicole.Ongele@fcc.gov. Include in the comments the OMB control number as shown in the SUPPLEMENTARY INFORMATION below. FOR FURTHER INFORMATION CONTACT: For additional information or copies of the information collection, contact Nicole Ongele at (202) 418–2991. To view a copy of this information collection request (ICR) submitted to OMB: (1) Go to the web page http://www.reginfo.gov/ public/do/PRAMain, (2) look for the section of the web page called ‘‘Currently Under Review,’’ (3) click on the downward-pointing arrow in the ‘‘Select Agency’’ box below the ‘‘Currently Under Review’’ heading, (4) select ‘‘Federal Communications Commission’’ from the list of agencies presented in the ‘‘Select Agency’’ box, (5) click the ‘‘Submit’’ button to the right of the ‘‘Select Agency’’ box, (6) when the list of FCC ICRs currently under review appears, look for the Title of this ICR and then click on the ICR Reference Number. A copy of the FCC submission to OMB will be displayed. SUPPLEMENTARY INFORMATION: As part of its continuing effort to reduce paperwork burdens, as required by the Paperwork Reduction Act (PRA) of 1995 (44 U.S.C. 3501–3520), the FCC invited the general public and other Federal Agencies to take this opportunity to comment on the following information collection. Comments are requested concerning: (a) Whether the proposed collection of information is necessary VerDate Sep<11>2014 20:12 Feb 14, 2022 Jkt 256001 for the proper performance of the functions of the Commission, including whether the information shall have practical utility; (b) the accuracy of the Commission’s burden estimates; (c) ways to enhance the quality, utility, and clarity of the information collected; and (d) ways to minimize the burden of the collection of information on the respondents, including the use of automated collection techniques or other forms of information technology. Pursuant to the Small Business Paperwork Relief Act of 2002, Public Law 107–198, see 44 U.S.C. 3506(c)(4), the FCC seeks specific comment on how it might ‘‘further reduce the information collection burden for small business concerns with fewer than 25 employees.’’ OMB Control Number: 3060–XXXX. Title: Preparation of Annual Reports to Congress for the Collection & Use of Fees for 988 Services by States & Other Jurisdictions Under the National Suicide Hotline Designation Act of 2020. Form Number: N/A. Type of Review: New information collection. Respondents: State, Local, or Tribal governments. Number of Respondents and Responses: 630 respondents; 630 responses. Estimated Time per Response: 55 hours. Frequency of Response: Annual reporting requirement. Obligation to Respond: Voluntary. Statutory authority for this information collection is contained in National Suicide Hotline Designation Act of 2020, Public Law 116–172, 134 Stat. 832 (2020) (988 Act). Total Annual Burden: 34,650 hours. Total Annual Cost: No Cost. Privacy Act Impact Assessment: No impact(s). Nature and Extent of Confidentiality: The Commission will consider the potential confidentiality of any information submitted, particularly where public release of such information could raise security concerns (e.g., granular location information). Respondents may request materials or information submitted to the Commission or to the Administrator be withheld from public inspection under 47 CFR 0.459 of the Commission’s rules. Needs and Uses: This information collection enables the Federal Communications Commission (Commission) to fulfill its continuing obligations under the National Suicide Hotline Designation Act of 2020, Public Law 116–172, 134 Stat. 832 (2020) (988 PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 Act), to submit an annual ‘‘Fee Accountability Report’’ to the Committees on Commerce, Science, and Transportation and Appropriations of the Senate, and the Committees on Energy and Commerce and Appropriations of the House of Representatives, detailing ‘‘the status in each State, political subdivision of a State, Indian Tribe, or village or regional corporation serving’’ an Alaska Native Claims Settlement Act region, of the collection and distribution of fees or charges for ‘‘the support or implementation of 9–8–8 services,’’ including ‘‘findings on the amount of revenues obligated or expended by each [state, political entity, and subdivision] for any purpose other than the purpose for which any such fees or charges are specified.’’ (988 Act, 134 Stat. at 833– 34.) The Commission will collect information for the preparation of the annual Fee Accountability Report through a survey, to be distributed via electronic mail, that appropriate officials of States and political subdivisions thereof, Indian Tribes, and village or regional corporations serving a region established pursuant to the Alaska Native Claims Settlement Act, as amended (43 U.S.C. 1601 et seq.) can use to submit data pertaining to the collection and distribution of revenues from fees and charges for the support or implementation of 988 services, including the use of such collected fees and charges for any purpose other than for the support or implementation of 988 services. In addition, consistent with the definition of ‘‘State’’ set forth in 47 U.S.C. 153(40) of the Communications Act, the Commission will collect this information from states as well as the District of Columbia and the inhabited U.S. Territories and possessions. Federal Communications Commission. Marlene Dortch, Secretary, Office of the Secretary. [FR Doc. 2022–03154 Filed 2–14–22; 8:45 am] BILLING CODE 6712–01–P FEDERAL ELECTION COMMISSION Sunshine Act Meeting Thursday, February 17, 2022 at 11:00 a.m. TIME AND DATE: 1050 First Street NE, Washington, DC. (This meeting will be a virtual meeting). PLACE: This meeting will be closed to the public. STATUS: E:\FR\FM\15FEN1.SGM 15FEN1 Federal Register / Vol. 87, No. 31 / Tuesday, February 15, 2022 / Notices Audit conducted pursuant to 52 U.S.C. 30111(b). * * * * * DEPARTMENT OF HEALTH AND HUMAN SERVICES CONTACT PERSON FOR MORE INFORMATION: [Docket No. FDA–2022–N–0072] MATTERS TO BE CONSIDERED: Food and Drug Administration Judith Ingram, Press Officer. Telephone: (202) 694–1220. Authority: Government in the Sunshine Act, 5 U.S.C. 552b. Laura E. Sinram, Acting Secretary and Clerk of the Commission. Data Standards; Requirement Begins for Version 3.1.1 of the Clinical Data Interchange Standards Consortium Standard for Exchange of Nonclinical Data Implementation Guide AGENCY: Food and Drug Administration, HHS. [FR Doc. 2022–03291 Filed 2–11–22; 11:15 am] ACTION: BILLING CODE 6715–01–P Notice. The Food and Drug Administration’s (FDA or Agency) Center for Biologics Evaluation and Research and (CBER) and Center for Drug Evaluation and Research (CDER) are announcing the date that support begins for version 3.1.1 of the Clinical Data Interchange Standards Consortium (CDISC) Standard for Exchange of Nonclinical Data Implementation Guide (SENDIG), and the date that this version update is required in certain submissions. The Agency will update the FDA Data Standards Catalog (Catalog) to reflect these changes. DATES: Support for version 3.1.1 of the CDISC SENDIG begins February 15, 2022. The requirement for electronic submissions to be submitted using version 3.1.1 of the CDISC SENDIG begins March 15, 2023, for new drug applications (NDAs), abbreviated new drug applications (ANDAs), certain biologics license applications (BLAs), and certain investigational new drug applications (INDs). ADDRESSES: You may submit either electronic or written comments at any time as follows. SUMMARY: FEDERAL RETIREMENT THRIFT INVESTMENT BOARD Notice of Board Meeting DATES: February 23, 2022 at 10:00 a.m. Telephonic. Dial-in (listen only) information: Number: 1–415–527– 5035, Code: 2763 825 4435; or via web: https://tspmeet.webex.com/tspmeet/ onstage/g.php?MTID=e668eeb9f8e4ab 246455527de529d7a2b. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Kimberly Weaver, Director, Office of External Affairs, (202) 942–1640. SUPPLEMENTARY INFORMATION: Board Meeting Agenda Open Session 1. Approval of the January 24, 2022 Board Meeting Minutes 2. Investment Manager Annual Service Review 3. Monthly Reports (a) Participant Activity Report (b) Investment Performance (c) Legislative Report 4. Investment Policy Review Frequency 5. Quarterly Report (d) Metrics 6. Converge Update 7. Agency Recognition Closed Session lotter on DSK11XQN23PROD with NOTICES1 8. Information Covered Under 5 U.S.C. 552b(c)(10) Authority: 5 U.S.C. 552b (e)(1). Dated: February 10, 2022. Dharmesh Vashee, General Counsel, Federal Retirement Thrift Investment Board. [FR Doc. 2022–03230 Filed 2–14–22; 8:45 am] BILLING CODE P VerDate Sep<11>2014 20:12 Feb 14, 2022 Jkt 256001 Electronic Submissions Submit electronic comments in the following way: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https:// www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else’s Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 8585 comments, that information will be posted on https://www.regulations.gov. • If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ‘‘Written/Paper Submissions’’ and ‘‘Instructions’’). Written/Paper Submissions Submit written/paper submissions as follows: • Mail/Hand Delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. • For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in ‘‘Instructions.’’ Instructions: All submissions received must include the Docket No. FDA– 2022–N–0072 for ‘‘Data Standards; Requirement Begins for Version 3.1.1 of the Clinical Data Interchange Standards Consortium Standard for Exchange of Nonclinical Data Implementation Guide.’’ Received comments will be placed in the docket and, except for those submitted as ‘‘Confidential Submissions,’’ publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday, 240–402–7500. • Confidential Submissions—To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states ‘‘THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.’’ The Agency will review this copy, including the claimed confidential information, in its consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on https://www.regulations.gov. Submit both copies to the Dockets Management Staff. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as ‘‘confidential.’’ Any information marked as ‘‘confidential’’ will not be disclosed except in accordance with 21 CFR 10.20 E:\FR\FM\15FEN1.SGM 15FEN1

Agencies

[Federal Register Volume 87, Number 31 (Tuesday, February 15, 2022)]
[Notices]
[Pages 8584-8585]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03291]


=======================================================================
-----------------------------------------------------------------------

FEDERAL ELECTION COMMISSION


Sunshine Act Meeting

TIME AND DATE: Thursday, February 17, 2022 at 11:00 a.m.

PLACE: 1050 First Street NE, Washington, DC. (This meeting will be a 
virtual meeting).

STATUS: This meeting will be closed to the public.

[[Page 8585]]


MATTERS TO BE CONSIDERED: Audit conducted pursuant to 52 U.S.C. 
30111(b).
* * * * *

CONTACT PERSON FOR MORE INFORMATION: Judith Ingram, Press Officer. 
Telephone: (202) 694-1220.
    Authority: Government in the Sunshine Act, 5 U.S.C. 552b.

Laura E. Sinram,
Acting Secretary and Clerk of the Commission.
[FR Doc. 2022-03291 Filed 2-11-22; 11:15 am]
BILLING CODE 6715-01-P